The Janssen COVID-19 Vaccine is one of four vaccines for the COVID-19 virus available in the United States. In Feburary of 2021, it received FDA's Emergency Use Authorization (EUA) for use in people aged 18 years and older. But since May of 2022, it's no longer a first-choice vaccine because of the risk of a serious side effect of rare blood clots. It should only be used in certain cases, such as when the other COVID-19 vaccines can't be used or aren't available. If you're getting Janssen COVID-19 Vaccine as your primary vaccine, you'll only need one dose.
Note: As of May 2023, Janssen COVID-19 Vaccine is no longer available in the United States.
Prevent COVID-19 infections in certain people aged 18 years and older
The Janssen COVID-19 Vaccine is a viral vector vaccine. It contains a slightly different, harmless version of the COVID-19 virus. When it's injected into your body, the vaccine tells your cells to make a part of the “spike protein” that's found on the virus that causes COVID-19. Your immune system recognizes that this spike protein doesn't belong in your body, so it produces antibodies against it. The antibodies tell other immune cells in your body to get rid of it. This teaches your body how to recognize the COVID-19 virus. So when you get infected with the real COVID-19 virus, your immune system is ready to fight and protect you from serious infection.
Source: FDA
Works well to lower your risk of hospitalization and death if you're infected with COVID-19
Primary series only require one dose
Can be used as a booster shot for COVID-19
Not authorized for people under 18 years of age
Not a first-choice COVID-19 vaccine because of the risk for blood clots
Lower rates of protection against the Omicron variant of COVID-19 compared with Comirnaty or Spikevax
The Janssen COVID-19 Vaccine will be injected into your muscle by a healthcare provider. This vaccine only requires one single injection.
If you're receiving the Janssen COVID-19 Vaccine as a booster dose after completing initial vaccination with the Janssen COVID-19 Vaccine, the booster should be given at least 2 months after your dose of the Janssen COVID-19 Vaccine.
If you're receiving the Janssen COVID-19 Vaccine as a booster dose after completing initial vaccination with one of the mRNA vaccines, such as Comirnaty (Pfizer-BioNTech) or Spikevax (Moderna), the booster should be given at least 5 months after completing the mRNA vaccination series.
The Janssen COVID-19 Vaccine can cause discomfort, such as pain, redness, or swelling, where you received the shot. To help with these side effects, you can apply a cool washcloth over the area where you got the injection. Moving your arm around can also help.
The Janssen COVID-19 Vaccine can also cause headaches, tiredness, fever, and muscle aches. If you develop a fever, be sure to drink plenty of fluids and dress in light clothing to avoid overheating.
Usually, feeling uncomfortable because of pain or a fever is a normal sign that your immune system is building protection against the COVID-19 virus. But if any side effects get worse after 24 hours or don't go away after a few days, it's best to contact your healthcare provider.
Don't take any over-the-counter medications, such as ibuprofen (Advil, Motrin), acetaminophen (Tylenol), or diphenhydramine (Benadryl), before receiving the Janssen COVID-19 Vaccine to prevent side effects. It's not known if they can affect how well the vaccine works. If needed, talk to your provider about taking these medications if you develop any side effects after getting the Janssen COVID-19 Vaccine.
Some people have fainted after getting the Janssen COVID-19 Vaccine. To prevent injuries caused by fainting, be sure to sit down while receiving your injection and while your provider is monitoring you afterwards.
Janssen COVID-19 Vaccine can cause some serious health issues. This risk may be even higher for certain groups. If this worries you, talk to your doctor or pharmacist about other options.
Risk factors: Females 18 to 49 years old
Although rare, the Janssen COVID-19 Vaccine can cause a serious blood clotting condition called thrombosis with thrombocytopenia syndrome. This is a condition that can cause blood clots in the brain, lungs, stomach, and legs, along with low levels of platelets (a type of blood cell that helps you stop bleeding). This condition is most common in females 18 to 49 years old. In some cases, it led to death. If you develop any signs of a blood clot, such as chest pain, shortness of breath, swelling or pain in your legs, stomach pain that won't go away, severe headaches, blurred vision, or tiny blood spots on your skin in areas beyond where the shot was given, get emergency medical help right away.
Risk factors: Age 50 years and older
Rarely, the Janssen COVID-19 Vaccine can cause Guillain-Barre syndrome, which is a condition where your immune system damages your nerves. This can lead to muscle weakness and paralysis. The risk of this condition is highest in the first 42 days after receiving the Janssen COVID-19 Vaccine. If you experience weakness or tingling in your arms or legs, trouble walking, trouble moving your mouth, jaw, or eyes, or difficulty controlling your bladder or bowels, get medical help right away.
Risk factors: Conditions that weaken your immune system (e.g., HIV/AIDS) | Taking medications that lower your immune system (e.g., prednisone, tacrolimus (Prograf))
If you have a weakened immune system, either due to a medical condition or medication that you're taking, your immune system might not respond as well to the Janssen COVID-19 Vaccine. This means you might not build up as strong of protection against the COVID-19 virus. Let your provider know if you have a weakened immune system.
Primary vaccination: The typical dose is a one-time injection of 0.5 mL into the muscle.
Booster: If you've received Janssen COVID-19 Vaccine, you can choose this vaccine as a booster if it's been at least 2 months since your primary dose. The typical dose is a one-time injection of 0.5 mL into the muscle.
Prevent COVID-19 infections in certain people aged 18 years and older
Prevention of COVID-19 infections in people ages 12 and older
Prevention of COVID-19 infections in children ages 6 months to 11 years - EUA only
Prevention of COVID-19 infections in people 12 years and older
Prevention of COVID-19 infections in children 6 months to 11 years - EUA only
By signing up, I agree to GoodRx's Terms and Privacy Policy, and to receive marketing messages from GoodRx.
Research prescriptions and over-the-counter medications from A to Z, compare drug prices, and start saving.